Navigation Links
SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
Date:1/29/2008

SAN DIEGO, Jan. 29 /PRNewswire/ --- SoluLinK, Inc., a leader in biomolecular conjugation products and kits, announced the introduction of their newest product, the ChromaLink Biotin Labeling Kit, a biotinylation reagent with a built-in measurement signature that comes as a complete, easy-to-use kit. ChromaLink is an innovative biotinylation reagent that includes a direct, non-destructive, UV measurement of incorporated biotin within a single reagent.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU010)

-- Complete Kit: All necessary reagents included as well as a foolproof

protocol provided on a flash drive

-- Built-in Quantitative Signal: Incorporated biotin quantified by simple

absorbance -- no HABA or fluoro-reporter assay needed -- only a simple

UV scan needed to measure

-- Versatile: Labels 25 micrograms to 1 mg of antibody

-- Safe and Economical: Water-soluble, mild on antibodies -- no DMF needed

"ChromaLink is the first in a line of our products designed to address existing market needs with effective technology, supplied in a complete, easy to use format. This line of products will provide complete assay solutions for specific market applications. SoluLinK's continuous and ongoing innovation of conjugation chemistry has provided significant contributions to our customers' and collaborators' ability to build greater value into their products. SoluLinK has established a strong leadership position in conjugation and continues to actively build, maintain, and manage our products and patented IP," observed Steve DeGraw, President of SoluLinK.

About SoluLinK

SoluLinK is a leader in the development of conjugation reagents, kits, and OEM services for the life sciences, diagnostic, and pharmaceutical communities. SoluLinK develops, manufactures, and markets bioconjugation products and services. Their proprietary bioconjugation linking chemistry is used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLinK's products include the conjugation of biomolecules for research assay, diagnostic, and pharmaceutical products. SoluLinK's proprietary ChromaLink Biotin Labeling Kit for biotinylation is one example. It is also the first product introduced from the pipeline of a new, easy to use kits that will help to enhance assay performance and measurement for customers in a broad range of large markets. SoluLinK markets these products both directly and through distributors and licensing partners world-wide. SoluLinK is a privately held company located in San Diego, California. For more information, please visit http://www.solulink.com.


'/>"/>
SOURCE SoluLinK, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
2. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
3. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
4. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
5. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
6. Finesse Introduces TruBio(TM) IOQ
7. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
8. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
9. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):